at 42 centers, and included patients with native VHDs, infective endocarditis, and/or previous valve interventions.
alvular heart diseases (VHD) are the most common causes of mortality and morbidity after coronary artery disease, hypertension, and heart failure. [1] Heart valve surgery comprises 10-30% of all cardiovascular diseases. [2, 3] In the last 60 years, with the eradication of acute rheumatic fever (ARF), degenerative etiologies have replaced rheumatic etiologies. [4, 5] Degenerative aortic stenosis (AS) and ischemic mitral regurgitation (MR) are the most common VHD in developed countries. [6] Moderate and severe VHDs occur with a frequency of 2.5 % in an echocardiographic study of 11.911 subjects in the USA, which found that the most common VHD is MR. [7] In a study in Europe (25 countries, 5001 patients), it was reported that the most common VHD is AS. [8] There is limited data on VHD in Turkey. In the "Turkish Adult Coronary Artery Diseases and Risk Factors Study" (2000) , it was estimated that 40.000 Turkish patients have VHD. [9] "The Turkish Registry on Heart Valve Diseases" (TRVD) was planned to evaluate disease types, symptoms, etiologies, affected valves, risk factors, laboratory tests, and treatment modalities of VHD.
PATIENTS AND METHODS

Study population and design
TRVD was carried out between June 2009 and June 2011. Patients with VHD admitted to the cardiology clinics in 33 cities from seven geographical regions in Turkey were included in the study. Informed consent was obtained from all patients, and the study protocol was approved by the ethics committee of Harran University Medical School (Number: 10.06.2009/06-13).
The patients were selected in accordance with the criteria of "The European Heart Survey (EHS) on valvular heart disease". [8] 
Data collection
Data were collected via the internet (https://ssl.epikriz.com/) from each hospital. The dataset comprised around 200 different parameters such as demographical variables like age, gender, education and the number of children, background, symptoms, co-morbidity risk factors, affected valves, etiologies, electrocardiographic (ECG) and echocardiographic (echo) findings, and suggested treatments. The etiologies of VHD were classified according to the history, clinical and echocardiographic findings. New York Heart Association (NYHA) criteria were applied in order to assess functional capacity. [10] 
Statistical analysis
Statistical analysis was carried out using SPSS software (version 11.5, SPSS Inc., Chicago, Illinois, USA). Results were presented as mean ± standard de- 
RESULTS
Patients
The study was carried out at 42 centers (4 private, 6 public, 32 university hospitals) by 50 researchers seeing a total of 1300 patients (mean age was 57±18 years, range: 19-101 years, 60% women). Nearly half of the patients were primary school graduates and only 8% of the patients were university graduates. The patients were divided into three groups: Native VHD (Group I, n=1090), previous intervention for VHD (Group II, n=201), and infective endocarditis (Group III, n=9). Native VHD patients were enrolled in the study at the first admittance, whereas patients who had undergone previous interventions were enrolled in the study during the follow-up period ( Table  1) . All of the patients with endocarditis were enrolled in the study at first diagnosis.
The most frequent native VHD was MR (43%) followed by multiple VHD (32%). Of the multiple VHD cases, 65% were double, 32% triple, and 3% involved quadruple valve disease. Most cases of MR were 2nd and 3rd degree and most cases of AR were 2nd degree. The majority of AS and MS patients had moderate stenosis (Fig. 1) . 74% (n=149) of the previous interventions were prosthetic valve replacement, and 90% (n=134) of these were mechanical prosthesis ( Table 2) . Tricuspid regurgitation accompanied mul- tiple VHD (40%) and MR (32%).
The most common cause of MS and multiple VHD is rheumatic etiology, whereas aortic VHD is primarily degenerative, and MR is degenerative and ischemic (Table 3 , Fig. 2 ). Mean age was lower in patients with congenital valve diseases and endocarditis compared with other groups (all p<0.05). Age was similar in patients with degenerative and ischemic VHD (p=0.343), and increased in the other VHD etiologies (Fig. 3) . In addition, AS was 90% congenital in subjects <40 years oldbut 100% degenerative among subjects ≥70 years of age. While AS increased with age, MS decreased (Fig. 4) .
The most important symptom was dyspnea (73%). Syncope was common in AS and palpitation was frequent in MS. Functional capacity was 43% in NYHA Class I, 38% in Class II, 15% in Class III, and 3% in Class IV patients with previous interventions. Of patients with native VHD, 21% were in Class I, 43% in Class II, 32% in Class III, and 4% had Class IV functional capacity.
Hypertension was the most frequent accompanying disease, followed by prior history of ARF. Hypertension was less frequent in MS compared to other VHDs, whereas history of ARF was more frequent 
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among patients with multiple VHD or MS (Table 3) .
Atrial fibrillation was present in 38% of patients with MS. Left ventricular ejection fraction was decreased in MR cases (ANOVA p<0.001). Left ventricular end-systolic and end-diastolic diameters were increased in patients with AR and MR (ANOVA p<0.001, Table 3 ).
It was found that clinical and the echo assessments were helpful in deciding treatment and that 14% of patients had catheterization and coronary angiography. Stress test was performed in only 1% of patients (Fig. 5) .
Treatment modalities
Interventional treatment was suggested for 15% of the subjects who had previously undergone interventions and for 26% of the patients with native VHD. While percutaneous balloon valvuloplasty (PBV) was preferred in MS, prosthetic valve replacement was selected in other VHDs (Fig. 6) . Bioprosthesis was applied in 10% of patients with prosthetic valve replacement. Despite the increased mean age of the patients with bioprosthesis relative to those with mechanical prosthesis, there was no significant difference between them (64±13 years vs. 54±15 years, p=0.076). 77% of bioprosthetic valve replacements were in the aortic position. 85% of patients who had prosthetic valve replacement were prescribed warfarin, and most of these patients (75%) were seen regularly during follow up care.
DISCUSSION
This study found that VHD was more common in patients with only primary school education, frequent among women, and that the most common cause of VHD was ARF. Dyspnea was the most common symptom, and the most frequent valve diseases were MR and multiple VHD. PBV was the most common treatment modality in MS and mechanic prosthetic valve replacement was the most common treatment modality in other VHDs.
Our study indicated that the most frequent VHDs were MR (43%) and multiple VHD (32%), and the most frequent etiologies were ARF (46%) and degenerative causes (29%). Ischemic etiology was more frequent in MR than among other VHDs. The EHS valve study is the most comprehensive epidemiologic work evaluating the etiology of VHD, tests, treatment, and results. The EHS study demonstrated that the most frequent VHDs were degenerative AS (33.9%) and MR (24.8%). [8] The findings of the present study were compatible with the previous surveys in that AS is congenital individuals under 40 years of age, and degenerative in those more than 70 yeas old. [5] [6] [7] MS occurred two-fold more frequently in women than in men, and its most common cause was ARF. [11] It was reported in the EHS study that ARF was the cause of MS in 85.4% of patients, and that 81% of these patients were women. [8] The present survey revealed that ARF was accounts for nearly all cases of MS (98%) and that 70% of these patients were women. The frequency of MS is 0.1% in USA, and 9% in Europe. [7, 8] We found an incidence of 15% in Turkey. This indicates that MS is more common in Turkey than in the USA and Europe.
Rheumatic heart diseases, especially common among the poor and in densely populated areas, are less common in countries where precautions are taken against rheumatic fever. [1, [12] [13] [14] Despite our major advances in medical technology and understanding, rheumatic fever remains a serious public health problem throughout the world. In a study conducted between 1980-2009, it was found that 1115 Turkish children had ARF, indicating that the frequency of this disease is higher in Turkey compared to developing countries. [15] Our study corroborates the finding that ARF is the primary etiology of VHD in adults.
While some surveys indicate that the frequency of VHD is similar in both genders, others show that MR and AR are more common among men (60-75%). [6, 16, 17] However, there is a higher prevalence of aortic valve stenosis in men than in women, whereas rheumatic heart disease is more frequent in women compared to men. [7, 12, 18, 19] Our findings are compatible with the latter (60% women).
In the present registry, 64% of patients had NYHA Class I-II symptoms indicating relatively early diagnosis. However, in the EHS study 29.5% of the patients had NYHA Class II and 43.1% had Class III symptoms. [8] The relatively high rate of the Class I symptoms among patients who had previous interventions suggests that treatment had a positive effect on functional capacity.
It is indicated in the valve studies carried out in Europe and USA that the valve disease frequency increases with age. [6] [7] [8] Our study also shows that while AS incidence increases with age, MS decreases and that there are no important differences among the other VHD regarding age.
EHS indicates that smoking (38.7%), hypertension (49.1%), diabetes mellitus (15.3%), hyperlipidemia (35.5%), and family history (25.7%) frequently accompany VHD. [8] Our survey indicates that, unlike the EHS study, hypertension, rheumatic fever history, and diabetes mellitus are occur frequently in individuals with VHD, but hyperlipidemia and smoking are less frequently associated with VHD.
Coronary angiography is recommended in diagnostic work-up if there is a risk of coronary artery disease in patients with symptomatic and significant VHD. [4, 11] The EHS study reported the use of coronary angiography in 43% of patients, catheterization in 31.1%, and stress tests in 7.9%. These interventions were less commonly used in our trial. Our study group had a lower mean age, a smaller number of cases with severe VHD (<50% vs. 66.7%), and fewer cases with previous intervention (15% vs. 28%) compared to the EHS study, potentially contributing to the differences in disease incidence between the two studies.
Age has been reported as the most important factor in prosthetic valve implantation, and bioprosthetic valve replacement was preferred in AS patients more than 65 years old. [8, 20, 21] Mean age was greater among cases with bioprosthetic valve replacement compared to cases with mechanical valve replacement. Bioprosthetic valve replacement was preferred in the treatment of AS in our study group, which is similar to previously published surveys. We speculate that this difference is not statistically significant due to the relatively low number of patients with bioprosthesis in our study group.
In the EHS study, PBV was applied in 33.9% of MS cases. [8] The lower rate of PBV in the EHS study might be attributed to old age, calcification, and deformation in the valve. [5, 6, 8] In addition, the EHS study indicated treatment of MR by surgical repair (46.5%), bioprosthetic valve replacement in elderly patients with AS, and mechanical valve replacement in other VHDs. [8] Our study determined that PBV is used in 10% of patients who had previous interventions and in 76% of MS patients. The reason for the difference between our finding (76%) and the EHS study finding (33.9%) may be the increased incidence of rheumatic fever as the origin of VHD, the relatively young age of our MS study group, valve structure, and the individual selection of doctors or patients in our dataset. It has been previously reported that PBV is frequently preferred in treatment of rheumatic VHD, [22] confirming our findings. Our survey indicates that valve repair is suggested for treatment of MR, which occurs with an incidence of 15%, much lower than reported by the EHS study. The difference might be due to a common degenerative origin of MR (61.3%), which is suitable for repair.
Limitations of the study
The main limitation of this study was the lack of follow-up data. In addition, some of the cases may be missing from the registry due to individual physician's personal preferrences.
Conclusions
The most frequent cause of valve diseases in Turkey is ARF. MR and multiple VHD are the most common forms of valve diseases. PBV and valve replacement are frequently suggested treatments in MS and in other VHDs. The effective primary prevention of rheumatic fever and increased awareness among the public would significantly decrease the burden of VHD in our country.
